SYMPHYTUM D 12 Dilution, 20 ml

Instructions for use for SYMPHYTUM D 12 Dilution, 20 ml

Directions for use of the article Symphytum D 12 Dilution Symphytum D 12 is a homeopathic medicinal product registered without a therapeutic indication. It contains 51% alcohol by volume and is available in the form of a liquid dilution. The package leaflet contains important information on the correct use of the medicinal product. Certain precautions should be observed before using Symphytum D 12. It must not be used in alcoholics and is contraindicated in cases of hypersensitivity to any of the ingredients. Medical advice should be sought in the case of persistent, unclear or new symptoms. In patients with liver disease, the medicine should only be used after consulting a doctor and children under 12 years of age should not take it due to the alcohol content. The use of Symphytum D 12 together with other medicinal products should be discussed with the doctor or pharmacist. The effect can be influenced by harmful factors in lifestyle as well as by stimulants and stimulants. Medical advice should be sought before use during pregnancy and lactation. No special precautions are required with regard to fitness for traffic and operation of machines. Possible side effects of Symphytum D 12 are not yet known. In the event of an overdose, consultation with a doctor should be sought. A forgotten application should not be compensated with a double dose and discontinuing the medicine has no harmful effects. Symphytum D 12 should not be stored above 25 °C and should be kept out of the reach of children. The medicinal product should not be used after the expiry date. The active substance of Symphytum D 12 is Symphytum (homeoph.) in a liquid dilution. It contains 51% alcohol by volume. Symphytum D 12 is manufactured by DHU-Arzneimittel GmbH & Co. KG, Ottostraße 24, 76227 Karlsruhe, Germany. Important information: For risks and side effects, read the package leaflet and ask your doctor or pharmacist. Source: Information in the package leaflet as of 04/2016.